Optimization of the Extragranular Excipient Composition of Paracetamol Tablet formulation using the Quality by Design Approach
DOI:
https://doi.org/10.1590/s2175-97902022e20544Keywords:
Optimization, Design of experiment, Extragranular excipients, Granule properties, Tablet propertiesAbstract
The purpose of this study is to optimize the composition of extragranular excipients (EGE) and mixing time of granules with EGE of paracetamol tablet formulation using Design of Experiments (DoE) approach. The effect of the composition of EGE and the mixing time of granules with EGE on granule and tableting properties of paracetamol tablet formulation was investigated using a combined model of mixture and process factors (Design-Expert 12). A total of 18 tablet formulations were manufactured by wet granulation using varying compositions of EGE and varying mixing time. Granule and tablet properties of each formulation were evaluated as response variables for the design, data generated were fitted into models and analysed to generate a design space that was used for optimization studies. The proposed EGE composition as predicted by the design was confirmed and validated after preparation and evaluation of the granule and tablet properties. The optimized composition for the EGE that yielded granules and tablets of desirable characteristics was found to be maize starch (5 %), talc (4.9 %) and magnesium stearate (0.1 %) with a mixing time of 2 min. The tablets produced with the optimized composition had better mechanical strength and disintegration time than the formulation prepared using an existing formula of maize starch (7.8 %), talc (2 %) and magnesium stearate (0.2 %) that were obtained using the One Variable at a Time (OVAT) approach. This study confirmed the relevance of quality by design in development of pharmaceutical formulations.
Downloads
References
Alebiowu G, Itiola OA. The influence of pregelatinized starch disintegrants on interacting variables that act on disintegrant properties. Pharm Technol. 2003;27(8):28-33.
Allen L, Popovich N, Ansel H. Powders and Granules. In: Allen L, Popovich N, Ansel H (eds) Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems, 8th edn. Lippincott Williams & Wilkins, New York, 2005, pp 186-203.
Almaya A, Aburub A. Effect of particle size on compaction of materials with different deformation mechanisms with and without lubricants. AAPS PharmSciTech. 2008;9(2):414-418.
Alves VML, Sá-Barreto LCL, Souza GHB, Cunha-Filho MSS. Co-processed extracts of Cassia angustifolia Vahl, Fabaceae, and Maytenus ilicifolia (Schrad.) Planch., Celastraceae, for production of high load tablets. Rev Bras Farmacogn. 2011;21(3):510-517.
Andrews GP. Advances in solid dosage form manufacturing technology. Phil Trans R Soc A. 2007;365(1861):2935-2949.
Apeji YE, Olowosulu AK. Quantifying the effect of glidant on the compaction and tableting properties of paracetamol granules. J Res Pharm. 2020;24:44-55.
Bodea A, Leucuta SE. Optimization of hydrophilic matrix tablets using a D-optimal design. Int J Pharm. 1997;153(2):247-255.
British Pharmacopoeia. British Pharmacopoeia, Volume II. Her Majesty’s Stationery Office, London, UK, 2013.
Chavan RB, Modi SR, Bansal AK. Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib. Int J Pharm . 2015;495(1):374-384.
Choudhari PK, Jain HK, Sharma P, Srivastava B. A novel co-processed directly compressible release-retarding polymer: In vitro, solid state and in vivo evaluation. Futur J Pharm Sci. 2018;4(1):29-40.
Debotton N, Dahan A. Applications of polymers as pharmaceutical excipients in solid oral dosage forms. Med Res Rev. 2017;37(1):52-97.
Desai PM, Liew CV, Heng PWS. Review of disintegrants and the disintegration phenomena. J Pharm Sci. 2016;105(9):2545- 2555.
Diarra H, Mazel V, Busignies V, Tchoreloff P. FEM simulation of the die compaction of pharmaceutical products: Influence of visco-elastic phenomena and comparison with experiments. Int J Pharm . 2013;453(2):389-394.
Hartesi B, Sriwidodo, Abdassah M, Chaerunisaa AY. Starch as pharmaceutical excipient. Int J Pharm Sci Rev Res. 2016;41(2):59-64
ICH. Q8(R2) Pharmaceutical Development. 2009
Jadhav N, Paradkar A, Salunkhe N, Karade RS, Mane GG. Talc: a versatile pharmaceutical excipient. World J Pharm Pharm Sci. 2013;2(6):4639-4660.
Kalies A, Heinrich T, Leopold CS. A novel approach to avoid capping and/or lamination by application of external lower punch vibration. Int J Pharm . 2020;580:119195.
Khampeng S, Otsuka M, Peerapattana J. A novel tablet disintegrant from Ocimum canum seeds. J Drug Deliv Sci Technol. 2019;51:18-25.
Miyamoto Y, Ryu A, Sugawara S, Miyajima M, Matsui M, Takayama K, et al. Optimization of the granulation process for designing tablets. Chem Pharm Bull. 1998;46(9):1432-1437.
Odeku OA, Akinwande BL. Effect of the mode of incorporation on the disintegrant properties of acid modified water and white yam starches. Saudi Pharm J. 2012;20(2):171-175.
Ogunjimi AT, Alebiowu G. Neem gum as a binder in a formulated paracetamol tablet with reference to acacia. AAPS PharmSciTech . 2014;15(2):500-510.
Ohwoavworhua FO, Adelakun TA. Non-wood fibre production of microcrystalline cellulose from sorghum caudatum: characterisation and tableting properties. Indian J Pharm Sci . 2010;72(3):295-301.
Patel S, Kaushal AM, Bansal AK. Compression physics in the formulation development of tablets. Crit Rev Ther Drug Carrier Syst. 2006;23(1):1-65.
Paul S, Sun C. Lubrication with magnesium stearate increases tablet brittleness. Powder Technol. 2017;309:126-132.
Perrault M, Bertrand F, Chaouki J. An experimental investigation of the effect of the amount of lubricant on tablet properties. Drug Dev Ind Pharm. 2011;37(2):234-242.
Pingali K, Saranteas K, Foroughi R, Muzzio F. Practical methods for improving flow properties of active pharmaceutical ingredients. Drug Dev Ind Pharm . 2009;35(12):1460-1469.
Rahmouni M, Lenaerts V, Massuelle D, Doelker E, Leroux JC. Influence of physical parameters and lubricants on the compaction properties of granulated and non-granulated cross-linked high amylose starch. Chem Pharm Bull . 2002;50(9):1155-1162.
Rajani C, Kumar DD, Jaya D, Kumar JA. Effects of granule particle size and lubricant concentration on tablet hardness containing large concentration of polymers. Braz J Pharm Sci . 2017;53(3):1-8.
Rodríguez-amado JR, Lafourcade-prada A, César J, Arranz E, Morris H, Colarte AI, et al. Optimization of a novel tablets’ formulation using D-optimal mixture design. African J Pharm Pharmacol. 2015;9(14):474-483.
Roy S, Hasan S, Kumar M. Effect of mode of addition of disintegrants on dissolution of model drug from wet granulation tablets. Int J Pharma Sci Res. 2011;2:84-92. https://www.ijpsr.info/docs/IJPSR11-02-02-12.pdf
» https://www.ijpsr.info/docs/IJPSR11-02-02-12.pdf
Singh B, Kapil R, Nandi M, Ahuja N. Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects. Expert Opin Drug Deliv. 2011;8(10):1341-1360.
Surajit P, Susanta KG. A desirability functions-based approach for simultaneous optimization of quantitative and ordinal response variables in industrial processes. Int J Eng Sci Technol. 2018;10(1):76-87.
Thapa P, Lee AR, Choi DH, Jeong SH. Effects of moisture content and compression pressure of various deforming granules on the physical properties of tablets. Powder Technol . 2017;310:92-102.
United States Pharmacopeia. USP NF. 2008.
United States Pharmacopeial Convention. USP Protocol for Dissolution studies. 2011.
Wang J, Wen H, Desai D. Lubrication in tablet formulations. Eur J Pharm Biopharm. 2010;75(1):1-15.
Yu LX. Pharmaceutical quality by design: Product and process development, understanding, and control. Pharm Res. 2008;25(4):781-791.
Zhang J, Wu CY, Pan X, Wu C. On identification of critical material attributes for compression behaviour of pharmaceutical diluent powders. Materials (Basel). 2017;10(7):845.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
